Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bora Lim

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
JCO Precision Oncology|March 14, 2024
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer SubtypesReva K Basho, Li Zhao, Jason B White, et al.
Nature|May 13, 2026
Ecotypes of triple-negative breast cancer in response to chemotherapyYun Yan, Yiyun Lin, Tapsi Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to ChemotherapyToshiaki Iwase, Evan N Cohen, Hui Gao, et al.
Molecular Cancer Therapeutics|May 13, 2025
Inhibition of MCL-1 and MEK overcomes MEK inhibitor resistance in triple-negative and inflammatory breast cancersMohd Mughees, Moises J Tacam, Alex W Tan, et al.
Science Translational Medicine|August 27, 2025
NF1-depleted ER<sup>+</sup> breast cancers are differentially sensitive to CDK4/6 inhibitorsZe-Yi Zheng, Anran Chen, Eric J Jaehnig, et al.
Plos One|September 29, 2017
Androgen receptor expression on circulating tumor cells in metastatic breast cancerTakeo Fujii, James M Reuben, Lei Huo, et al.
Cancer|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
Cancers|May 30, 2019
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective ImmunotherapyRama Soundararajan, Jared J Fradette, Jessica M Konen, et al.
Frontiers in Artificial Intelligence|August 29, 2022
Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerEhsan Irajizad, Ranran Wu, Jody Vykoukal, et al.
Journal of Cancer|May 4, 2018
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary ConferenceNaoto T Ueno, Jose Rodrigo Espinosa Fernandez, Massimo Cristofanilli, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
JCO Precision Oncology|March 14, 2024
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer SubtypesReva K Basho, Li Zhao, Jason B White, et al.
Nature|May 13, 2026
Ecotypes of triple-negative breast cancer in response to chemotherapyYun Yan, Yiyun Lin, Tapsi Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to ChemotherapyToshiaki Iwase, Evan N Cohen, Hui Gao, et al.
Molecular Cancer Therapeutics|May 13, 2025
Inhibition of MCL-1 and MEK overcomes MEK inhibitor resistance in triple-negative and inflammatory breast cancersMohd Mughees, Moises J Tacam, Alex W Tan, et al.
Science Translational Medicine|August 27, 2025
NF1-depleted ER<sup>+</sup> breast cancers are differentially sensitive to CDK4/6 inhibitorsZe-Yi Zheng, Anran Chen, Eric J Jaehnig, et al.
Plos One|September 29, 2017
Androgen receptor expression on circulating tumor cells in metastatic breast cancerTakeo Fujii, James M Reuben, Lei Huo, et al.
Cancer|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
Cancers|May 30, 2019
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective ImmunotherapyRama Soundararajan, Jared J Fradette, Jessica M Konen, et al.
Frontiers in Artificial Intelligence|August 29, 2022
Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerEhsan Irajizad, Ranran Wu, Jody Vykoukal, et al.
Journal of Cancer|May 4, 2018
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary ConferenceNaoto T Ueno, Jose Rodrigo Espinosa Fernandez, Massimo Cristofanilli, et al.
Pageof 15